Condition

Tuberculosis, Pulmonary

ClinicalTrials.gov condition label

Clinical trials19

Recruiting1

Common interventions25

Lead sponsors shown15

Clinical trials

19 shown

Atorvastatin to Reduce Inflammation After Tuberculosis Treatment CompletionNCT04147286 · 2020-07-14

RECRUITING

Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible TuberculosisNCT05556746 · 2023-11-24

ACTIVE_NOT_RECRUITING

The INSTITUT Study Tuberculosis Nutritional SupportNCT06084715 · 2023-09-07

COMPLETED

Pharmacist-Led Intervention to Improve TB Treatment AdherenceNCT06608069 · 2023-09-01

COMPLETED

Collision of Three Global Pandemics: the Effect of Tuberculosis and HIV on the Epidemiological, Clinical, Virological and Immunological Trajectory of COVID-19 in Botswana and NamibiaNCT05268380 · 2022-08-01

COMPLETED

INSTI's For The Management of HIV-associated TBNCT04734652 · 2022-02-18

COMPLETED

Evaluation of a Rapid Point-of-Care Serological Triage Test for Active TBNCT04752592 · 2021-09-21

COMPLETED

DIAGNOSIS of PULMONARY TUBERCULOSIS Through HUMAN BREATH (TBENOSE)NCT04682990 · 2021-01-05

COMPLETED

POC Strategies to Improve TB Care in Advanced HIV DiseaseNCT04122404 · 2019-10-14

COMPLETED

Study to Evaluate H56:IC31 in Preventing Rate of TB RecurrenceNCT03512249 · 2019-01-31

COMPLETED

A Pragmatic Randomised Study to Optimise Screening, Prevention and Care for Tuberculosis in MalawiNCT03519425 · 2018-11-15

UNKNOWN

Rifampicin vs Rifabutin in HIV/AIDS Patients Combined With TuberculosisNCT03478033 · 2018-04-15

UNKNOWN

RIPE vs RIPE Plus N-acetylcysteine in Patients With HIV/TB Co-infectionNCT03281226 · 2016-12-07

UNKNOWN

Microbiome in Pulmonary Tuberculosis, Non-tuberculous Mycobacterial Pulmonary Diseases, Lung Cancer and HemoptysisNCT04079400 · 2016-12-01

COMPLETED

Feasibility of a Lateral Flow Urine LAM Test for Diagnosis of Tuberculosis in South AfricaNCT01693224 · 2011-04-01

UNKNOWN

Feasibility of a Lateral Flow Urine Lipoarabinomannan (LAM) Test for Diagnosis of TuberculosisNCT01525134 · 2011-01-01

UNKNOWN

Pharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized PatientsNCT01364324 · 2010-09-01

COMPLETED

Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and TuberculosisNCT05065905 · 2006-01-19

COMPLETED

Diagnosing Tuberculosis in HIV Infected Children in PeruNCT00054769 · 2002-03-01

COMPLETED

Common interventions

Alere "Clearview" ELISA urine LAM assayDEVICE2Alere "Determine" lateral-flow urine lipoarabinomannan assayDEVICE2Atorvastatin 40mgDRUG1Bedaquiline (BDQ)DRUG1Biktarvy®COMBINATION_PRODUCT1Cepheid Xpert MTB/Rif assayDEVICE1Chest X-RayOTHER1Clofazimine (CFZ)DRUG1Covid-19, TB and HIV diagnosisDIAGNOSTIC_TEST1Delamanid (DLM)DRUG1Educational counsellingBEHAVIORAL1Ethambutol (EMB)DRUG1Follow Up & 15 days after beginning of Tx.OTHER1Follow Up & 30 days after beginning of Tx.OTHER1Follow Up 5 days after beginning of Tx.OTHER1H56:IC31BIOLOGICAL1Interferon-GammaDRUG1Isoniazid (INH)DRUG1LF-LAMDIAGNOSTIC_TEST1Nutritional supportOTHER1Optimised HIV screening and linkage to careOTHER1Optimised tuberculosis screening and linkage to careOTHER1PlaceboBIOLOGICAL1Placebo oral tabletDRUG1Pyrazinamide (PZA)DRUG1

Leading sponsors

Tuberculosis Clinical Diagnostics Research Consortium2Boston Medical Center1Brigham and Women's Hospital1Centre for the AIDS Programme of Research in South Africa1Fundação de Medicina Tropical Dr. Heitor Vieira Dourado1Gachon University Gil Medical Center1International AIDS Vaccine Initiative1Liverpool School of Tropical Medicine1National Cancer Center, Korea1National Institute of Allergy and Infectious Diseases (NIAID)1Norwegian Institute of Public Health1Shanghai Public Health Clinical Center1SPP Pharmaclon Ltd.1Universiti Sains Malaysia1University of Cape Town1

Trial status mix

COMPLETED12

UNKNOWN5

ACTIVE_NOT_RECRUITING1

RECRUITING1

Phase mix

NA8

PHASE26

PHASE11

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.